CINC
CinCor Pharma, Inc. Common Stock
CINC
CINC
Delisted
CINC was delisted on the 23rd of February, 2023.
102 hedge funds and large institutions have $461M invested in CinCor Pharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
62% less capital invested
Capital invested by funds: $1.21B → $461M (-$752M)
68% less call options, than puts
Call options by funds: $2.68M | Put options by funds: $8.47M
Holders
102
Holding in Top 10
4
Calls
$2.68M
Puts
$8.47M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$8.82M | |
| 3 | +$5.71M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.05M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$4.86M |
Top Sellers
| 1 | -$43.1M | |
| 2 | -$18.2M | |
| 3 | -$12.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$8.98M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.42M |